[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SRPT mentions surge with high engagements, but concerns arise over milestone payments and potential return of rights to ARWR.
This report summarizes social media activity and engagement related to Sarepta Therapeutics, Inc. (SRPT).
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXX
1 Month: XXXXXX +168%
1-Year High: XXXXX on 2025-07-16
1-Year Low: X on 2025-06-15
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X no change
1 Month: X +100%
1-Year High: X on 2025-07-26
1-Year Low: X on 2025-06-06
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $srpttype in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X no change
1 Month: X no change
1-Year High: X on 2025-06-06
1-Year Low: X on 2025-06-06
Top assets mentioned In the posts about $srpttype in the last XX hours
Arrowhead Research Corporation (ARWR) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT)
Top topics mentioned In the posts about $srpttype in the last XX hours
cns, $arwr, $srpt, sarepta therapeutics inc, $325m, $500m
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Interesting scenario = market increasingly pricing in $SRPT unable to pay milestones & returning rights for TRiM candidates in CNS/muscle to $ARWR As $ARWR was able to extract $500M upfront + $325M in equity first time around (+ milestones/royalties) have to wonder what they get for repartnering IF initial DM1 data promising 🤔"
@jfais20 on X 2025-07-24 18:52:15 UTC 10.1K followers, 4291 engagements